MCT Oil (Medium Chain Triglycerides)
SupplementThe community rates MCT oil slightly higher than the clinical evidence warrants, attributable to subjectively perceived energy effects and the halo effect of the ketogenic diet [c1, c2]. The medical evidence, by contrast, shows only moderate effect sizes for weight and cognition and no relevant athletic performance effect [s3, s6].
Unlock full information
Dosages, side effects, studies and more — free after registration.
Register for freeRating Scales
TL;DR
MCT oil is one of the few supplements with genuine RCT evidence: modest weight loss versus LCT (SMD ~-0.3) and cognitive support in Alzheimer's disease are replicated findings, though effect sizes are small. No meaningful evidence exists for athletic performance. GI side effects from too-rapid dose escalation are significant — slow titration is a necessity, not a suggestion. C8 oil (caprylic acid) produces the most ketones; expensive branded blends rarely offer added value.
Description
MCT oil provides rapidly available energy from medium-chain fatty acids, supports ketosis, and is used in ketogenic diets, weight management, and for cognitive support [...]
MCT oil consists of medium-chain triglycerides (C8–C12), derived primarily from coconut oil or palm kernel oil. The most relevant fatty acids are caprylic acid [C8], capric acid [C10], and lauric acid [C12]. Unlike long-chain fatty acids (LCT), MCTs are transported directly from the intestine via the portal vein to the liver, bypassing the lymphatic system [s1]. There, rapid beta-oxidation occurs with formation of ketone bodies (β-hydroxybutyrate, acetoacetate), which serve as alternative energy sources for the brain and musculature [s2, s4]. MCT oil is particularly prevalent in ketogenic diets, as it promotes ketone production without requiring strict carbohydrate elimination [s2]. Clinical studies show moderate benefit for weight management (vs. LCT) and for Alzheimer-related cognitive impairment [s3, s4, s5]. Evidence for athletic performance enhancement, however, is weak [s6]. Main components compared: Pure C8 MCT oil produces ketone bodies most rapidly and is better tolerated; blends containing C12 (lauric acid) are less expensive but less ketogenic [s2]. The German Nutrition Society (DGE) considers MCT not recommendable for obesity therapy due to inconsistent long-term data [s12].
Legal Status (DE)
MCT oil is freely marketable in the DACH countries as a food or dietary supplement without requiring authorization. It is considered an established food in the EU without novel food status and is subject to general food legislation (NemV, Regulation 2002/46/EC) [s10, s11].
Mechanism of Action
Following oral ingestion, MCTs are transported directly via the portal vein to the liver, without chylomicron-bound lymphatic transport as seen with LCTs [s1]. In the liver, they are rapidly degraded by beta-oxidation, generating acetyl-CoA that enters the ketone body synthesis pathway (ketogenesis) [s2]. Caprylic acid [C8] exhibits the highest rate of ketone production [s2]. Ketone bodies (particularly β-hydroxybutyrate) can cross the blood-brain barrier and serve neurons as an alternative energy source when glucose metabolism is impaired — relevant in Alzheimer's dementia, where cerebral glucose hypometabolism is observed [s4, s5]. Thermogenic effect: MCTs increase diet-induced thermogenesis and fat oxidation to a greater extent than LCTs, which may lead to a slightly elevated energy expenditure [s3, s12]. However, this effect is small and of limited clinical relevance [s3]. For athletic performance, MCTs theoretically provide rapid energy, but the ergogenic effect has been rated as minimal in systematic reviews [s6].
Dosing
Kognitive Unterstützung bei Alzheimer / MCI
- Dose
- 20–30 g MCT oil daily
- Frequency
- 1× täglich
- Route
- oral
- With food
- optional
Side Effects
| Side Effect | Frequency | Severity |
|---|---|---|
| Durchfall, wässriger Stuhl | gelegentlich | leicht |
| Übelkeit, Erbrechen | gelegentlich | leicht |
| Abdominale Krämpfe, Blähungen | gelegentlich | leicht |
| Erhöhung der LDL-Cholesterin-Werte | gelegentlich | leicht |
Contraindications
MCTs are metabolized directly in the liver; impaired hepatic function carries a risk of ketoacidosis and hepatic damage [s8].
MCTs increase ketone production; in the setting of insulin deficiency, there is a risk of exacerbating ketoacidosis [s8].
Although MCTs are better absorbed than LCTs, exocrine pancreatic insufficiency and severe malabsorption can lead to worsened GI symptoms [s7].
Interactions
Synergistic
MCT oil and ALCAR complement each other synergistically in fat metabolism. MCT oil provides rapidly available ketones, while carnitine supports the transport of fatty acids into mitochondria. This combination may optimize ketone production and energy supply.
MCT oil substantially improves the bioavailability of fat-soluble CoQ10, as MCTs act as a lipophilic carrier system. Studies demonstrate increased intestinal absorption of CoQ10 with concurrent MCT intake.
MCT oil enhances the uptake of fat-soluble vitamins D3 and K2, as these depend on dietary fats for absorption in the small intestine. This combination is frequently used in commercial formulations.
As a highly lipophilic carotenoid, astaxanthin benefits from concurrent intake with MCT oil, as this significantly improves intestinal absorption.
Curcumin has well-known poor bioavailability, which can be improved by combination with MCT oil. Fats increase the solubility and absorption of curcumin in the gastrointestinal tract.
MCT oil and berberine may act synergistically on glucose and lipid metabolism. MCTs promote ketone production and reduce blood glucose, while berberine improves insulin sensitivity.
Caution
MCT oil (medium-chain triglycerides) is used as a ketogenic dietary component and may affect serum levels of certain anticonvulsants (e.g., valproate, phenobarbital) through altered absorption, protein binding, or hepatic metabolism. Close monitoring of anticonvulsant levels is recommended during concurrent use, as both loss of efficacy and increased toxicity are possible.
The combination of MCT oil and berberine may cause excessive blood glucose reduction when taken concurrently with hypoglycemic agents. Individuals with diabetes or other metabolic disorders should use this combination under medical supervision.
Studies
Tier A — High Evidence
Outcome: Weight change and body composition vs. LCT
Effect Size: Significantly lower weight gain with MCT vs. LCT; SMD approx. -0.3 kg
Outcome: Athletic endurance performance and substrate utilization
Effect Size: No relevant ergogenic effect; 30 g/day identified as safe maximum dose
Outcome: Cognitive function in Alzheimer's disease and MCI (ADAS-cog)
Effect Size: Significant positive effect on general cognition (SMD -0.289; 95% CI -0.551 to -0.027)
Outcome: Plasma ketone concentrations and cerebral metabolism in dementia
Effect Size: Substantial increase in plasma ketones and improvement in cerebral metabolic rates
Outcome: Weight loss in overweight/obesity vs. LCT
Effect Size: Significant reduction in body weight and metabolic parameters; recommendation for pure MCT
Tier B — Moderate Evidence
Outcome: Mechanism of MCT absorption and metabolism
Effect Size: Narrative; direct portal vein transport vs. chylomicron-bound LCT transport described
Outcome: Thermogenesis and fat oxidation following MCT vs. LCT
Effect Size: Higher diet-induced thermogenesis with MCT, but inconsistent long-term data; not recommended for obesity treatment
Tier C — Low Evidence
Outcome: MCT oil as a component of the ketogenic diet in epilepsy
Effect Size: Reduction in seizures reported; lacks CNS side effects of typical antiepileptics; larger studies required
Community Evidence
Top reported benefits
- Sustained energy in bulletproof coffee without energy crash
- Support of ketosis on a low-carbohydrate diet
- Subjectively improved mental clarity and concentration
- Appetite reduction in some users
Top reported issues
- Diarrhea and loose/watery stools, especially at the beginning
- Nausea when taken on an empty stomach
- Headaches in some users
- No noticeable effect in some users
Frequent criticism of exaggerated marketing claims (e.g., "HUGE brain benefits"). Experienced users in r/keto and r/biohacking recommend gradual dose escalation and emphasize that GI side effects can be substantial without slow titration. Skepticism toward expensive branded products compared to cheaper C8/C10 blends is widespread [c1, c2, c3].
Scientific Sources
- MCT Oil: Health Benefits, Common Uses and Side Effects
WebMD Editorial Contributors (2023). WebMDCLink - Directive 2002/46/EC of the European Parliament and of the Council on the approximation of the laws of the Member States relating to food supplements
European Parliament, Council of the European Union (2002). Official Journal of the European CommunitiesALink - Medium-Chain Triglycerides: Scientific and Regulatory Perspectives from Germany and Japan with a US Context—A Concise Review
Yanagita T, Nagao K, Inoue N, et al. (2025). Nutrients (MDPI)BDOI - Mittelkettige Triglyceride für die Adipositastherapie nicht empfehlenswert
Deutsche Gesellschaft für Ernährung (DGE) (2021). DGE FachinformationALink - MCT-Öl: Vorkommen, Einsatzgebiete und Effekte – MCT und Epilepsie
Moleqlar Editorial Team (2023). Moleqlar LexikonCLink - The impact of medium-chain triglycerides on weight loss and metabolic health in individuals with overweight or obesity: A systematic review and meta-analysis
Ye Y, Zhang T, Yao X, et al. (2024). Clinical NutritionAPMID:38936302DOI - Acute Effects of Medium Chain Triglyceride (MCT) Nutritional Ketosis on Parkinson's Disease Symptoms and Biomarkers (MCT-PD) — Protocol/SAP
Fortier M, Nugent S, Castellano CA, et al. (2020). CLink - Medium-Chain Triglyceride Oil and Blood Lipids: A Systematic Review and Meta-Analysis of Randomized Trials
Zhu Y, Tsai MY, Sun Q, et al. (2022). Journal of NutritionCDOI - A randomised trial of classical and medium-chain triglyceride ketogenic diets in the treatment of childhood epilepsy
Neal EG, Chaffe H, Schwartz RH, Lawson MS, Edwards N, Fitzsimmons G, et al. (2009). EpilepsiaCPMID:19220814DOI - Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled, multicenter trial
Henderson ST, Vogel JL, Barr LJ, Garvin F, Jones JJ, Costantini LC (2009). Nutrition & MetabolismCPMID:19664276DOI - Medium-chain triglyceride - Wikipedia
Wikipedia Contributors (2024). WikipediaCLink - Effects of medium-chain triglycerides on weight loss and body composition: a meta-analysis of randomized controlled trials
Mumme K, Stonehouse W (2015). Journal of the Academy of Nutrition and DieteticsAPMID:25636220DOI - The Effects of Medium Chain Triglyceride for Alzheimer's Disease Related Cognitive Impairment: A Systematic Review and Meta-Analysis
Avgerinos KI, Egan JM, Bhatt DL, et al. (2023). Journal of Alzheimer's Disease (PMC)ADOI - Medium-Chain Triglycerides (MCTs) for the Symptomatic Treatment of Dementia-Related Diseases: A Systematic Review
Meer N, Bilal A, Abdulkarim H, et al. (2024). Journal of Nutrition and MetabolismADOI - The Effects of Medium-Chain Triglyceride Oil Supplementation on Endurance Performance and Substrate Utilization in Healthy Populations: A Systematic Review
Goss AM, Dowla S, Pendergrass M, et al. (2022). PubMed / NutrientsAPMID:36096496DOI - MCT Oil Side Effects: Diarrhoea, Nausea, and Bloating — Dose-Dependent Onset and Prevention Protocol
BeKeto Editorial Team (2024). BeKeto.ukCLink - What are the contraindications of MCT (Medium-Chain Triglyceride) oil?
DrOracle Medical Editorial (2024). DrOracle.aiCLink - Best MCT oil 2026 — evidence-based roundup
Factually Editorial Team (2026). Factually.coCLink
Community Sources
Storage
Unopened
Store in a cool, dark, and dry place; stable at room temperature (up to 25°C).
Opened
After opening, store in a cool, light-protected location; keep container tightly sealed.
Notes
MCT oil is more susceptible to oxidation than saturated LCTs, but more stable than polyunsaturated oils. Glass bottles are preferred; watch for discoloration or rancid odor. Not suitable for high-temperature cooking (smoke point approx. 160°C) [s2].